Team:Freiburg/Team

Overview Motivation CAR T Cells Tumor Microenvironment AND Gate Outlook Achievements References

Members Attributions Partners Contact

Main Project Modeling Applied Design Proof of Concept BioBricks Basic Part BioBrick Improvement Interlab Study

Safety Cloning HIF1A Knockdown Cell Culture Lab Book

Human Practice Integrated Human Practice Collaborations

Team Members

This year the Freiburg iGEM team consist of 14 students from various fields, such as medicine, biology, chemistry and theology. Together we worked hard to achieve something outstanding this year. We receive perpetual support from Dr. Maximilian Ulbrich (BIOSS) and Dr. Nicole Gensch (BIOSS). In addition, we could benefit from the experience of six former iGEM members, our immediate supervisors Julika Neumann, Katharina Ostmann, Philipp Schwenk, Danja Steinberg, Lara Stühn and Nathalie Wössner.

Cancer is one of the most important challenges medical research has to overcome. Cancer tissue originates from healthy cells mainly through genetic changes which dysregulate cellular processes especially growth and metabolism. For this reason the treatment is challenging, as each cancer is different and keeps changing, making it difficult to find the best therapy. Common approaches such as radiation or chemotherapy can lead to severe short and long-term side-effects.

Cancer is one of the most important challenges medical research has to overcome. Cancer tissue originates from healthy cells mainly through genetic changes which dysregulate cellular processes especially growth and metabolism. For this reason the treatment is challenging, as each cancer is different and keeps changing, making it difficult to find the best therapy. Common approaches such as radiation or chemotherapy can lead to severe short and long-term side-effects.